As the supply of venture dollars is rapidly
shrinking, the task of seeking funds is becoming even more difficult. More
importantly than seeking, is the effort of being able to obtain the fund. The
annual IBF MedTech Investing Conference, that took place in Minneapolis last
week, provided some tips on how to fulfill this task.
These tips to obtain fund in the medical device
industry can be simplified in three C’s: cost, clinical outcomes and CMS (Centers for Medicare and Medicaid Services -
reimbursement). Cost is referred to if the new
technology/product can remove expenses from the system. The second C, clinical
outcomes, is referred to if patients are doing better with the new technology.
Investors want to see clinical evidence and proof that the new product is
superior than the treatments already available on the market. And finally, the
third C, CMS, is about reimbursement. Investors want to know if the Centers of
Medicaid and Medicare will cover the procedure. It is common sense that there
is a special highlight for cost, though.
Despite of being challenging, companies that can
demonstrate their command of the three C’s are more likely to obtain funds.